Results 11 to 20 of about 162,186 (348)

Subunit vaccines for Acinetobacter baumannii

open access: yesFrontiers in Immunology, 2023
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen in hospitals. A. baumannii infection has become a challenging problem in clinical practice due to the increasing number of multidrug-resistant strains and their ...
N. Yang   +6 more
semanticscholar   +4 more sources

Tackling Acinetobacter baumannii

open access: yesJournal of Clinical Medicine, 2023
Globally, multidrug-resistant (MDR) bacteria represent a menace to public health [...].
G. Granata, F. Taglietti, N. Petrosillo
semanticscholar   +3 more sources

Acinetobacter baumannii [PDF]

open access: yesTrends in Microbiology, 2022
Acinetobacter baumannii is a ubiquitous, Gram-negative, nonflagellated coccobacillus bacterium commonly isolated from the environment. In human medicine, this opportunistic pathogen is responsible for hospital- and community-acquired infections. Resistance to last-resort antibiotics, such as colistin, tigecycline, and carbapenems, earns this bacterium ...
Clémence Whiteway   +3 more
openaire   +5 more sources

Acinetobacter baumannii [PDF]

open access: yesVirulence, 2012
Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospital-acquired infections. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrug-resistant (MDR) strains, has significantly raised the ...
Howard, Aoife   +3 more
openaire   +3 more sources

Acinetobacter Baumannii Phages: Past, Present and Future

open access: yesViruses, 2023
Acinetobacter baumannii (A. baumannii) is one of the most common clinical pathogens and a typical multi-drug resistant (MDR) bacterium. With the increase of drug-resistant A.
Qihang Tu   +9 more
semanticscholar   +1 more source

Resistance mechanisms of tigecycline in Acinetobacter baumannii

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a common pathogen causing various infectious diseases. Currently, the drug resistance rate of A.
Chunli Sun, Yunsong Yu, X. Hua
semanticscholar   +1 more source

Drug‑resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics (Review)

open access: yesExperimental and Therapeutic Medicine, 2023
Bacterial drug resistance is increasingly becoming an important problem that needs to be solved urgently in modern clinical practices. Infection caused by Acinetobacter baumannii is a serious threat to the life and health of patients. The drug resistance
Hao Wu   +7 more
semanticscholar   +1 more source

Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection

open access: yesFrontiers in Medicine, 2022
Acinetobacter baumannii (A. baumannii) is a leading cause of nosocomial infections as this pathogen has certain attributes that facilitate the subversion of natural defenses of the human body. A.
S. Roy   +4 more
semanticscholar   +1 more source

Investigating bacteriophages targeting the opportunistic pathogen Acinetobacter baumannii [PDF]

open access: yes, 2020
The multi-drug resistance of the opportunistic pathogen Acinetobacter baumannii is of growing concern, with many clinical isolates proving to be resistant to last resort as well as front line antibiotic treatments.
Christie, Gabrielle S.   +10 more
core   +1 more source

Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review

open access: yesInfection and Drug Resistance, 2021
Acinetobacter species, particularly Acinetobacter baumannii, is the first pathogen on the critical priority list of pathogens for novel antibiotics to become a “red-alert” human pathogen. Acinetobacter baumannii is an emerging global antibiotic-resistant
A. Gedefie   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy